BackLakeShore Biopharma Co Ltd. - Warrants (15/03/2028) Overview
LakeShore Biopharma Co Ltd. - Warrants (15/03/2028)

LakeShore Biopharma Co Ltd. - Warrants (15/03/2028) Return on Equity

Valuation check: LSBPW's ROE is -42.28%, below the sector sector average of -4.47%.

Get informed when a big investor buys or sells

+ Follow

ROE

-42.28%

Return on Equity

-42.28%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

Average ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

LakeShore Biopharma Co Ltd. - Warrants (15/03/2028) (LSBPW) FAQ

LakeShore Biopharma Co Ltd. - Warrants (15/03/2028) posts a ROE of -42.28%. That is below the sector sector average of -4.47%. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

For its sector stocks, a ROE near -4.47% is typical. LakeShore Biopharma Co Ltd. - Warrants (15/03/2028)'s -42.28% is lower that level. That is roughly 846.3% below the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.

LakeShore Biopharma Co Ltd. - Warrants (15/03/2028)'s ROE moves when the underlying profit, equity, or asset base changes. Cost cuts, pricing power, buybacks, write-downs, and cyclical swings can all shift the percentage. The latest reading is -42.28%; use YoY and peer views to separate noise from signal.

Context for LSBPW's ROE usually means three checks: (1) trend versus prior periods, (2) level versus peers (average -4.47%), and (3) consistency with growth and profitability. This page covers the first two; LakeShore Biopharma Co Ltd. - Warrants (15/03/2028)'s other metric pages and overview cover the third.